低级结质瘤中的端粒维护途径:从遗传亚型和端粒长度动态的洞察
Meline Hakobyan1, Hans Binder2,3, Arsen Arakelyan1
1Bioinformatics Group, Institute of Molecular Biology National Academy of Sciences of the Republic of Armenia (NAS RA), Yerevan 0014, Armenia.
International journal of molecular sciences
|May 14, 2025
概括
端粒维护途径在低度质瘤 (LGG) 亚型之间有显著差异. IDH野生型瘤显示出更高的替代延长端粒 (ALT) 途径活性,这表明这些侵袭性癌症的新治疗点.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 遗传学 是一个遗传学.
背景情况:
- 端粒维持机制 (TMM) 在癌症中至关重要,但在较低级别质瘤 (LGGs) 中尚不清楚.
- 了解LGG中的端粒动态和通路活性对于开发向疗法至关重要.
研究的目的:
- 为了研究不同LGG基因亚型的端粒长度变化和TMM活性.
- 通过分析 LGG 中的端粒维护途径来确定潜在的治疗点.
主要方法:
- 对端粒长度,通路活性和生存数据的TCGA-LGG和CGGA数据集的分析.
- 使用GEO COPD和GBM数据集进行验证,并进行严格的数据处理和批量效应校正.
- 分型特异性分析侧重于IDH和ATRX突变状态.
主要成果:
- 短端粒和长端粒组之间的端粒酶 (TEL) 路径激活显著差异,TERT发挥着关键作用.
- 显著的替代延长端粒 (ALT) 途径活动模式,在IDH野生型 (IDH-wt) 瘤中最高,由RAD51.1驱动.
- 在IDH-wt/ATRX野生型 (WT) 瘤中观察到的最短的端粒长度和最高的ALT活性.
结论:
- 在LGG基因亚型中存在不同的端粒调节动态.
- TERT是端粒维护的核心,而ALT通路活动是亚型特定的.
- 研究结果为针对LGG中TMM的潜在治疗策略提供了新的见解.
更多相关视频
09:09Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion
Published on: April 12, 2020
6.8K
05:45Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
9.6K
相关概念视频
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Telomeres and Telomerase
5.0K
5.0K
Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
